All news (page 47)

15 June 2026

DL E&C wins KRW550bn EPC for Dongjeju combined cycle power plant

150MW gas-fired combined cycle plant in Jeju, hydrogen-ready and due 2030; will use AWP and a synchronous condenser to support grid stability and future hydrogen conversion.
15 June 2026

EIB: Egypt and EU invest €690 million to modernise Egypt's electricity grid

Up to €690m will fund grid upgrades to integrate 22 GW of solar and wind by 2030, cut transmission losses, improve reliability and reinforce Egypt as a regional clean‑energy hub.
15 June 2026

Nobian commissions fully electrified MVR salt plant in Mariager

Fully electrified MVR salt plant starts operation in Mariager, boosting capacity ~60% to up to 1 million tons/yr while cutting energy use and CO₂ emissions.
15 June 2026

Takeda’s oveporexton improved function, cognition and nighttime sleep in narcolepsy type 1

Phase 3 secondary/exploratory endpoints showed benefits across daily functioning, cognitive measures and REM sleep patterns; NDA has Priority Review with a Q3 PDUFA goal date.
15 June 2026

Videberg Kraft selects Rolls‑Royce SMR for three reactors at Värö Peninsula

Detailed planning starts for three modular PWR reactors (470 MW each) expected to produce ~12 TWh/year; supplier choice follows a four-year evaluation of more than 70 options.
15 June 2026

Eastman acquires Jarylec dielectric brand from Arkema

Acquisition covers trademarks, customer list, technical documentation and IP for dielectric fluids used in high‑voltage transformers; production stays in Marl, Germany.
15 June 2026

UPM Adhesive Materials 2025 Climate Review: emissions cuts and value-chain collaboration

58% cut in scope 1–2 emission intensity vs 2015, expanded supplier carbon data, product footprints cover ~94% of label sales, and recycling services support release liner waste recovery.
15 June 2026

Croda’s Avanti Polar Lipids partners with NovoArc to expand lipid offering for pharma research

Adds advanced lipid technologies offering improved stability and enabling new delivery routes for mRNA, protein and peptide therapeutics; initially for research use with scale-up development.
15 June 2026

Stahl acquires Weilburger Graphics packaging coatings business in Brazil

Acquisition adds Weilburger Graphics' Brazil packaging coatings portfolio; production to be insourced in 2026 and local manufacturing capacity expanded; closing pending approvals.
15 June 2026

Statkraft to build Blåfjell Pump into Blåsjø reservoir

Pump will lift water ~60 m into Norway’s largest hydropower reservoir, adding 54 GWh to Ulla‑Førre output; four local contracts awarded totalling NOK 250m.
15 June 2026

LKAB granted environmental permit for expanded Malmberget operations

Court allows continued and expanded mining and processing in Malmberget, including a demo fossil-free sponge iron plant and an apatite processing line for Luleå supply.
15 June 2026

Equinor advances Johan Sverdrup phase 4 subsea development

Appraisal wells confirmed 20–30 million boe in Tonjer and Geitungen; planned subsea tie-back to maintain Johan Sverdrup production with possible start-up in 2029.
15 June 2026

Symrise renews and ups €750m revolving credit facility

Refinanced existing RCF and increased volume to €750m with five-year term, two one-year extension options and a €250m accordion; terms aided by investment-grade ratings.
15 June 2026

OMV Petrom advances Gabare solar-plus-storage into development

Final investment decision for Gabare: ~415 MWp PV with ~600 MWh BESS, EUR 300m investment, first production targeted for 2028.
15 June 2026

Mitsui Chemicals — Developing Dental Materials M&A as a Third Growth Pillar

Acquire Ultradent to build a US dental materials platform, lift L&HC to ¥86bn by FY30 (ROS 17%), and capture whitening growth amid broader specialty-chemicals repositioning.
15 June 2026

Sinopec launches 9,436 km² 3D continuous seismic processing project

Largest continuous 3D seismic processing campaign covers 9,436 km² to support Sichuan Basin exploration, reserve growth and well targeting.
14 June 2026

Lilly: Jaypirca plus venetoclax‑rituximab lowers progression risk 45% in relapsed/refractory CLL/SLL

Phase 3 BRUIN CLL-322 found adding pirtobrutinib to a two‑year venetoclax+rituximab regimen reduced progression or death by 45% versus venetoclax+rituximab alone.
13 June 2026

Lilly reports Phase 1 results for AJ1-11095, a first‑in‑class type II JAK2 inhibitor

Phase 1 data show 70% SVR35 and TSS50 rates, VAF reductions in 21/23 patients, no dose‑limiting toxicities; expansion and further indications planned.
13 June 2026

Johnson & Johnson: TALVEY plus DARZALEX FASPRO shows superior PFS and OS in Phase 3 MonumenTAL‑3

GPRC5D bispecific plus anti‑CD38 combo cut progression risk and delivered 24‑month PFS up to 81% and OS up to 89% in earlier‑line relapsed/refractory multiple myeloma.
13 June 2026

Genmab: Epcoritamab shows high response rates in elderly first‑line DLBCL with mono and R‑mini‑CHOP regimens

Fixed‑duration subcutaneous epcoritamab produced rapid, durable responses and high MRD negativity in elderly newly diagnosed DLBCL patients ineligible for full‑dose anthracycline therapy.
12 June 2026

Chiyoda: Demonstration of next-generation remote O&M using IOWN APN

Testing a low-latency, zero-jitter photonic network to enable real-time remote monitoring, control and anomaly detection for regional plants.
12 June 2026

SunGas ends Beaver Lake bio-methanol project

Planned wood-fiber-to-low-carbon-methanol plant near Alexandria will not proceed, citing slow market uptake, CCS and regulatory/financing uncertainty.
12 June 2026

Roche VENTANA PTEN (SP218) FDA-cleared as PTEN companion diagnostic in prostate cancer

First FDA-cleared IHC companion diagnostic to detect PTEN protein loss and select patients for capivasertib (TRUQAP) plus abiraterone therapy.
12 June 2026

Merck: FDA approves KEYTRUDA and KEYTRUDA QLEX with WELIREG for adjuvant ccRCC

FDA cleared PD‑1 plus HIF‑2α adjuvant regimens after Phase 3 showed 28% lower recurrence risk and 81% vs 74% 24‑month DFS; notable anemia, hypoxia and treatment discontinuations.
12 June 2026

BASF’s Tinosorb S (bemotrizinol) approved by FDA as first new U.S. sunscreen active in 27 years

FDA clears bemotrizinol, a broad‑spectrum, photostable UV filter that enables longer‑lasting, stronger UVA/UVB protection and improved formulation stability.
12 June 2026

Mitsui Chemicals to acquire Ultradent via U.S. holding company

Acquiring Utah-based dental-products maker for $900M; will combine Ultradent with Kulzer, move oral-care HQ to the U.S., and target closing in Sept 2026.
12 June 2026

Chugai files Tecentriq for maintenance therapy after definitive chemoradiotherapy in locally advanced esophageal cancer

Submission seeks approval of an anti‑PD‑L1 agent as maintenance therapy after definitive chemoradiotherapy, supported by SKYSCRAPER‑07 Phase III interim results.
12 June 2026

GSK’s momelotinib gains orphan drug status in US and EU for VEXAS

Orphan designations back development of momelotinib for VEXAS; ATLAS phase II/III underway with design to be shown at EHA 2026.
12 June 2026

Sinopec and Inner Mongolia sign comprehensive strategic cooperation agreement

Regional government and state energy group agree to deepen project-level cooperation, align development plans and expand projects including hydrogen, carbon fiber and coal-chemicals.
11 June 2026

Enagás launches public participation plan for 44 km hydrogen backbone in Murcia

Conceptual public participation plan opened for a 44 km hydrogen pipeline in Murcia, with local events and info points; part of Spain’s wider 2,600 km Hydrogen Backbone programme.

← Previous Next →